Similar articles

• Live attenuated influenza virus vaccines in patients with chronic broncho-pulmonary diseases. Clinical and immunological evaluation.

  Prevost JM, Vereerstraeten-Schmerber J, Lamy F, De Koster JP. Prevost JM, et al. Scand J Respir Dis. 1975 May;56(1):58-69. Scand J Respir Dis. 1975. PMID: 1096297 Clinical Trial.
• Immune response in persistent infection. Further studies on persistent respiratory infection in man with para-influenza type 3 virus.

  Gross PS, Green RH, Lerner E, Curnen MG. Gross PS, et al. Am Rev Respir Dis. 1974 Nov;110(5):676-81. doi: 10.1164/arrd.1974.110.5.676. Am Rev Respir Dis. 1974. PMID: 4372917 No abstract available.
• II. Primary and secondary immunological response of experimental animals to attenuated and nonattenuated measles virus.

  Aleksandrowicz J, Polna I, Sadowski W. Aleksandrowicz J, et al. Acta Microbiol Pol A. 1973;5(3):139-45. Acta Microbiol Pol A. 1973. PMID: 4203633 No abstract available.
• [Effectiveness of inactivated vaccines against influenza].

  Peradze TV, Fridman EA. Peradze TV, et al. Zh Mikrobiol Epidemiol Immunobiol. 1982 Sep;(9):28-34. Zh Mikrobiol Epidemiol Immunobiol. 1982. PMID: 6755982 Review. Russian. No abstract available.
• [Effectiveness of inactivated vaccines against influenza].

  Fridman EA, Peradze TV. Fridman EA, et al. Tr Inst Im Pastera. 1982;58:84-94. Tr Inst Im Pastera. 1982. PMID: 6764983 Review. Russian. No abstract available.